Title: “New Directions in Atopic Dermatitis Management: Harnessing the Power of Social Learning to Improve Patient Outcomes”

Presented by: Johns Hopkins School of Medicine

Release Date: August 24, 2022

Expiration Date: August 24, 2023

Estimated time to complete this activity: 2 hours and 30 minutes. This activity has been approved for a maximum of 2.50 AMA PRA Category 1 Credits™.

Fees and Prerequisites: There are no fees or prerequisites.

Acknowledgement of Commercial Support: Supported by an independent educational grant from Pfizer Inc.

Target Audience

This activity is intended to meet the educational needs of allergists, pediatric allergists, dermatologists, pediatric dermatologists, advanced practitioners (NPs and PAs), and other healthcare professionals who are involved in the care and treatment of patients with Atopic Dermatitis.

Learning Objectives

After participating in this activity, learners will demonstrate the ability to:

• Discuss patient evaluation strategies to diagnose moderate to severe AD early and accurately across various skin types. 
• Describe the pathobiology of AD and the rationale for targeted therapies.
• Evaluate efficacy and safety profiles of current and emerging targeted therapies for AD to make informed therapy selection for patients. 
• Devise personalized care plans for patients with AD appropriate for differences in age and ethnicity. 
• Educate patients with AD on clinical symptoms and treatment options to optimize their own care and improve outcomes.

Presented by the Johns Hopkins School of Medicine

Accreditation Statement 

The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement  

The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 2.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Credits

American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

American Association of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

American Academy of PAs (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. PAs may receive a maximum of 2.50 AAPA Category 1 Credit for completing this program.

Statement of Need

Clinically heterogeneous presentation, with only intermittent symptoms and long latent periods for some patients, along with manifestations that overlap with other skin conditions make the diagnosis of atopic dermatitis difficult for clinicians, resulting in delays in diagnosis and treatment. Current therapies such as topical corticosteroids, emollients, supportive care and biologics have limited efficacy and are not adequate for treating many patients with moderate to severe AD across different skin types. To bridge this gap, novel targeted therapies are needed. Investigational therapies such as Janus Kinase 1 (JAK 1) inhibitors, monoclonal antibodies, and membrane IgE inhibitor when approved will transform the treatment approaches for AD. These advancements will provide more treatment options for patients and will allow clinicians to specifically treat underlying causes of AD with more certainty. However, substantial accumulation of new data from these advances creates knowledge and practice gaps that affect patient care. This collaborative social learning platform establishes a network of providers who can support each other locally, as well as those from different communities, with the goal of learning and sharing best practices that will improve outcomes for patients with atopic dermatitis.

Johns Hopkins Faculty:

Corinne Savides Happel, MD
Assistant Professor of Medicine 
Allergy and Immunology 
Johns Hopkins Hospital
Baltimore, MD

Policy on Speaker and Provider Disclosure

It is the policy of the Johns Hopkins University School of Medicine that the speaker and provider globally disclose conflicts of interest. The Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to presentation of the education.

Johns Hopkins Statement of Responsibility

The Johns Hopkins School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

Internet CME Policy

The Office of Continuing Medical Education (OCME) at the Johns Hopkins School of Medicine is committed to protecting the privacy of its members and customers. Johns Hopkins School of Medicine OCME maintains its Internet site as an information resource and service for physicians, other health professionals and the public. OCME at the Johns Hopkins School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet based program. Your information will never be given to anyone outside of the Johns Hopkins School of Medicine CME program. CME collects only the information necessary to provide you with the services that you request.  

Copyright

All rights reserved - The Johns Hopkins School of Medicine. No part of this program may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embodied in articles or reviews.

Format and Method of Participation

Review this internet-based CME activity. To take the post-test, please click on the post-test button below the video window of the player which will take you to the Johns Hopkins School of Medicine’s website. If you already have registered for other programs at this website, simply enter the requested information when prompted. Otherwise, complete the registration form to begin the testing process. The information you enter here will be used to generate your CME certificate. Please complete all fields to ensure accurate registration. Complete the post-test and evaluation and attest to the amount of time spent in the activity. Upon receiving a score of 70% or above, print your CME certificate.

Baseline Assessment: 0.25 AMA PRA Category 1 Credit™
Module 1 – Considerations for the Care of Pediatric Patients with Atopic Dermatitis: .50 hours of AMA PRA Category 1 Credit™
Module 2 – Considerations for the Care of Adult Patients with Atopic Dermatitis: .50 hours of AMA PRA Category 1 Credit™
Two Live Sessions: 0.25 AMA PRA Category 1 Credit™ each for a total of .50 hours of CME
Two Group Task: 0.25 AMA PRA Category 1 Credit™ each for a total of .50 hours of CME
Final Assessment: 0.25 AMA PRA Category 1 Credit™

Full Disclosure Policy Affecting CME Activities

As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), Johns Hopkins School of Medicine Office of Continuing Medical Education (OCME) requires attested and signed global disclosure of the existence of all financial interests or relationships with commercial interest from any individual in a position to control the content of a CME activity sponsored by OCME. The following relationships have been reported for this activity:

Faculty

Corrine Happel, MD – Membership on Advisory Committees or Review Panels, Board Membership, etc.: Verywell

Note: Grants to investigators at The Johns Hopkins University are negotiated and administered by the institution which receives the grants, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).

Off-Label Discussion 

There are no references to off-label/unapproved uses of products in this program.

Disclaimer

The opinions and recommendations expressed by faculty and other experts, whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of the Johns Hopkins School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

Privacy Statement/Internet Policy

The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protecting the privacy of its members and customers. The Johns Hopkins School of Medicine CME maintains its Internet site as an information resource and service for physicians, other health professionals and the public. Continuing Medical Education at the Johns Hopkins School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet-based program. Your information will never be given to anyone outside of the Johns Hopkins School of Medicine's CME program. Continuing Medical Education collects only the information necessary to provide you with the services that you request.

AMERICANS WITH DISABILITIES ACT

The Johns Hopkins School of Medicine fully complies with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if you have any special needs.